IMCB

IMCB (Gemabank) is a medical company and market leader among stem cell banks in Russia. It offers services in collection, isolation, cryopreservation and storage of PC ICs. It occupies about 44% of the Russian market at the end of 2018 by the number of samples in storage.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

IMCB balance sheet

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Capitalization, ₽
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

IMCB cash flows

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Sales
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

IMCB multipliers

Report period2017 2018 2019 2020 2021 2022
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

IMCB profitability

Report period2017 2018 2019 2020 2021 2022
ROA
ROE
ROS
EBITDA Margin
Operating margin
IMCB assets
IMCB cash flows
IMCB dividends
8.81%

IMCB shares

TickerNameTypeNominal valueISINPrice
GEMA:RMIMCBCommon shareRUB 0.01RU000A100GC7RUB 143.3

IMCB bonds

NameIssue sizePriceYield
IMCB JSC BO-P01-02 (RUB)200,000 pcs.88.21%19.41%
IMCB JSC BO-P01-01 (RUB)30,000 pcs.96.01%12.39%
Share capital structure of IMCB
IMCB news
17.03.2025
IMCB's RAS net profit for 2024 amounted to ₽151.2 million, up 20.2% from ₽125.8 million in the previous year. Revenue rose 23% to ₽348.6 million against ₽283.5 million a year earlier.
Source: {source} pictogram e-disclosure.ru
Pictogram next
09.12.2024
Shareholders of IMCB approved dividends for 9 months 2024 in the amount of ₽2.7 per ordinary share. The last day of purchase of securities to receive dividends is December 16, 2024. Dividend yield may amount to 2.13%.
Source: disclosure.skrin.ru
Pictogram next
31.10.2024
Board of Directors of IMCB recommended that dividends be paid for 9 months 2024 in the amount of ₽2.7 per ordinary share. The last day of the purchase of securities to receive dividends is December 16, 2024. Dividend yield may amount to 1.97%.
Source: {source} pictogram e-disclosure.ru
Pictogram next
29.10.2024
IMCB's RAS net profit for 9 months of 2024 amounted to ₽115.1 million, up 5.7% from ₽108.9 million in the previous year. Revenue increased by 20.2% to ₽256.6 million against ₽213.4 million a year earlier.
Source: {source} pictogram e-disclosure.ru
Pictogram next
All IMCB news
General information
Company nameIMCB
Tags#biotechnology, #innovations of the russia, #stem cells
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business addressgorod Moskva
Mailing address119333, g. Moskva, ul. Gubkina, d. 3, korp. 1, etazh 1, pom. 1, komn. 24
CEOPrihodko Aleksandr Viktorovich
Phone+7(495) 646-80-76
Websiteinvest.gemabank.ru
Information disclosuree-disclosure.ru